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Stem cells and bFGF in tendon healing:
Effects of lentiviral gene transfer and
long-term follow-up in a rat Achilles
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T. M. Kraus1,3*†, F. B. Imhoff1†, J. Reinert1, G. Wexel1, A. Wolf2, D. Hirsch2, A. Hofmann1, U. Stöckle3, S. Buchmann1,
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Abstract
Background: The influence of stem cells and lentiviral expression of basic fibroblastic growth factor (bFGF) on
tendon healing and remodelling was investigated in an in-vivo long-term (12 weeks) rat Achilles tendon
defect model.
Methods: In sixty male Lewis rats, complete tendon defects (2.4 mm) were created and either left untreated
(PBS) or treated by injection of stem cells lentivirally expressing the enhanced green fluorescence marker
gene eGFP (MSC-LV-eGFP) or basic fibroblast growth factor bFGF (MSC-LV-bFGF). Tendons were harvested
after 12 weeks and underwent biomechanical and (immuno)-histological analysis.
Results: After 12 weeks the mean ultimate load to failure ratio (treated side to contralateral side) in
biomechanical testing reached 97 % in the bFGF-group, 103 % in the eGFP-group and 112 % in the
PBS-group. Also in the stiffness testing both MSC groups did not reach the results of the PBS group.
Histologically, the MSC groups did not show better results than the control group. There were clusters of
ossifications found in all groups. In immunohistology, only the staining collagen-type-I was strongly increased
in both MSC groups in comparison to PBS control group. However, there were no significant differences in
the (immuno)-histological results between both stem cell groups.
Conclusion: The biomechanical and (immuno)-histological results did not show positive effects of the MSC groups on
tendon remodelling in a long-term follow-up. Interestingly, in later stages stem cells had hardly any effects on
biomechanical results. This study inspires a critical and reflected use of stem cells in tendon healing.
Keywords: Growth factor, Mesenchymal stem cells (MSCs), Tendon healing, bFGF, Lentiviral vector
Background
The healing potential of tendons is reported to be infer-
ior to bone, skin and other connective tissue [1]. In
general tendon healing is relatively slower than the
healing of other connective tissues and regenerated
tendons are of biomechanical/histological minor quality
and strength [2, 3]. However, as tendon ruptures cause a
considerable loss of function effort has been made to
improve primary tendon healing as well as to increase
the quality of the repaired tissue. In recent research the
most promising results derived from studies that applied
bone-marrow-derived mesenchymal stem cells (MSC) in
order to accelerate Achilles tendon healing in rabbit [4]
or rat rupture models [5]. The effects of tendon healing
or tendon-/bone healing with the application of MSCs,
bone marrow derived cells (BMCs) or adipose tissue
derived stem cells is well investigated [5–7]. MSCs may
contribute to healing not only by direct differentiation
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but also by the release of growth factors such as IGF-1,
TGF-ß, VEGF, PDGF, and bFGF [8–10]. One of the most
promising aspects of stem cell application to healing
tissue is furthermore the modulation of the healing
process. Until today it is not exactly known when, how
and in which concentration growth factors are needed to
improve the healing process [2, 11].
As a another aspect, of all growth factors especially
bFGF resulted in an increase of collagen-type-I and
collagen-type-III production [12], which might therefore
strengthen the biomechanical and histological properties
of regenerative tendons. Previous short-time studies
showed partially positive, partially negligible effects of
MSC and bFGF after short-time investigation [13].
Therefore the aim of this study was to assess the healing
potential of rat Achilles tendons in a defect model after
treatment with lentiviral bFGF transduced mesenchymal
stem cells (MSC-LV-bFGF) after a healing period of twelve
weeks in comparison to stem cells alone. Until today the
combination of mesenchymal stem cells together with
viral bFGF transduction on tendon healing has only been
analysed after shorter periods.
Methods
Study design
Sixty male Lewis-rats were divided into three groups: an
eGFP-MSC group (mesenchymal stem cells lentivirally
expressing enhanced green fluorescent protein), a bFGF-
MSC group (mesenchymal stem cells expressing bFGF
lentivirally), and a control PBS (phosphate buffered saline)
group. After complete dissection of the left Achilles
tendon with a 2.4 mm arthroscopy punch (Arthrex,
Naples, USA) the tendon was treated randomly with injec-
tion of either PBS, MSC-LV-eGFP or MSC-LV-bFGF. The
right tendon remained untreated as a control for biomech-
anical testing. After the healing period of 12 weeks the
treated tendons were harvested. In each group, ten tendons
were used for biomechanical testing, and ten underwent
histological analysis.
Procedures involving animal care and treatment were
conducted in conformity with the institutional guidelines
that are in compliance with national and international
laws (DIRECTIVE 86/609/EEC; German animal welfare
law; FELASA guidelines). The ethical committee for
animal experiments of upper Bavaria approved the study
protocol (No. 55.2-1-54-2531-55-09).
Stem cells
Isolation of rat mesenchymal stem cells from tibia
and femur bone marrow from male Lewis rats was
performed as described by Lennon et al [14]. Stem
cells were cultured as described by Neuhuber et al.
[15] for lentiviral transduction, differention assays and
cell transplantation.
As described by Wubbenhorst et al. [16] a third
generation packaging system was used to produce
VSV.G-pseudotyped, self-inactivating lentiviral vectors
expressing eGFP or bFGF under control of the spleen
focus-forming (SF) virus promoter, respectively, by transi-
ent transfection of 293 T cells [16]. Passage 2 MSC were
infected with lentiviral supernatants in presence of 8 μg/
ml polybrene (Sigma-Aldrich, Germany) over night.
Characterization of rat MSC was performed according
to Kraus et al. [13]. The mesenchymal stem cell character-
istics had been verified by differentiation assays showing
adipogenic, chondrogenic, and osteogenic differentiation
potential in vitro as well as transduction efficiency and
bFGF expression. bFGF transduction resulted in a sixty-
fold increase of bFGF proteins in comparison with non-
transduced and eGFP-transduced cells [13].
For each application a suspension of 100 μl was
prepared. The minimum amount of 106 MSC was
assured for every injection. Suspensions were prepared
at the day of surgery for immediate use.
Animals
Fourteen week old male Lewis rats (LEW/Crl inbred) were
obtained from Charles River (Sulzfeld, Germany) with a
mean body weight at point of surgery of 395 ± 25 g (stand-
ard deviation). Acclimatization lasted at least 14 days.
Animals were kept at room temperature of 22 ± 2 °C.
Lighting was provided by a 12–hour on-off cycle.
Two animals were housed together in a standard
open-top Makrolon type-IV cage (Tecniplast, Italy)
with autoclaved sawdust bedding and hay. Rat corner
houses (Bioscape GmbH, Germany) and pulp as nest-
ing material were offered to the rats. They had ad
libitum access to water and food (Altromin, Germany).
Health monitoring was performed accordingly to the
recommendations of FELASA (2002) except for Hanta-
virus. In the rat unit Pasteurella pneumotropica and Rat
Minute Virus were detected irregularly.
Surgical procedures
The surgical procedures were performed under veterinary
supervision. The rats were randomly dedicated to one of
the three groups. Weight was measured prior to each
surgery. After inducing the anaesthesia with an intra-
muscular injection (into the right hindlimb) of medetomi-
dine (0.15 mg/kg), midazolam (2 mg/kg), and fentanyl
(0.005 mg/kg) the left hindlimb was shaved and disin-
fected (Cutasept F; isopropanol; Bode, Germany). 100 %
Oxygen was added to the respiratory air, a heating mat
was used to prevent cooling and the vital signs were moni-
tored. Surgery was performed under sterile conditions.
The left Achilles tendon was laid open with a skin
incision of approximately 15 mm on the medial side of
the left hind limb. An arthroscopic punch (size 2.4 mm)
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was placed around the Achilles tendon in a distance of
approximately 2 mm from the calcaneal bone (Fig. 1).
The injection of 100 μl of cell suspension proximally
and distally to the designated tendon defect was per-
formed using a syringe. Then, the tendon was com-
pletely dissected and was not sutured. The skin was
sutured intracutaneously with 4-0 absorbable Mono-
cryl (poliglecaprone; Johnson & Johnson, Germany).
The suture was followed by OpSite spray-on dressing
(Smith & Nephew, Germany). Afterwards animals re-
ceived metamizole (200 mg/kg) s.c. for immediate
postoperative analgesia.
Anaesthesia was antagonized with an s.c. injection of
atipamezole (0.75 mg/kg), flumazenile (0.2 mg/kg) and
naloxon (0.12 mg/kg). After awakening buprenorphine
(0.05 mg/kg) was injected s.c. for analgesia. Animals
received postoperative analgesia over three days after
surgery (buprenorphine 0.05 mg/kg/12 h s.c. and meta-
mizole 200 mg/kg/12 h p.o.). No immobilization was
applied and no partial weight-bearing model was used
throughout the healing period.
Sample collection
After 12 weeks the rats were anesthetized with inhal-
ation of 2 % isoflurane and then euthanized in deep
anaesthesia with an intravenous overdose of pentobar-
bital (80 mg/kg). Both tendons were prepared and
harvested as a whole with the triceps surae muscle on
the proximal site and the calcaneal bone distally. Tendons
for biomechanical analysis were immediately frozen (-18°
Celsius). Tendons designated for immunohistological ana-
lysis were prepared carefully by removing muscle and
bone. Fixation was done with 70 % methanol and tendons
were stored at +8° Celsius.
Statistical analysis
Results of the biomechanical testing after twelve weeks
healing period were analyzed across treatments using
one-way ANOVA. The independent variable treatment
with the characteristics PBS, eGFP and bFGF defined
the groups for comparison.
The results after the 12 weeks healing period were
compared with the results of the previous study (14 or
28 days healing period) using two-tailed unpaired t-tests.
Statistical significance was assumed at p < 0,05. SPSS
software was used for statistical analysis (SPSS v21.0.0.0.0
for Mac OS; SPSS Inc.).
Biomechanical testing
Thawed Achilles tendons were prepared for biomechan-
ical testing by blunt dissection of excessive muscle tissue
from the muscle-tendon-junction. The tendons under-
went macroscopic assessment and standardized picture
documentation. The proximal end was fixed in a cryo-
clamp. The distal end of the Achilles tendon was placed
in a mounting grid to lock the calcaneal bone into pos-
ition. For testing, a mechanical testing machine (Zwicki
1120, Zwick, Ulm, Germany) was used. Preload was set
to 2 N, then the tendons were axially pulled at a
constant speed of 0.16 mm/s until maximum load to
failure. Room temperature was kept constant at 21°
Celsius (Fig. 2).
Considering the diverse constitution of the rats,
contralateral tendons were tested in the same way for
percentage statistical analysis (matched pairs). SPSS
software was used for calculation of stiffness and ultim-
ate load to failure (SPSS v21.0.0.0.0 for Mac OS; SPSS
Inc., IBM Company).
Histological analysis
After methanol fixation tendons were decalcified using
10 % EDTA solution (HNaO Sodium hydroxide S5881
Sigma, Germany; EDTA A3234 AppliChem, Germany) for
three to six weeks under control by X-ray (30 kV and 10 s;
X-ray equipment: Cabinet x-ray systems faxitron series, HP,
Germany and X-ray film: Structurix D4DW 18 × 24, NDT
Systems, Agfa, Germany). Then tendons were transferred
to 100 % methanol. Twenty-four hours prior to cryosec-
tioning, tissue samples were stored in a 5 % sucrose
and phosphate-buffered saline solution. Sections were
sliced to thickness of twelve micrometers (Cryostat
CM 1950, Leica, Germany and Cryo Gel Embedding
Fig. 1 a injection of suspension. b creation of the tendon defect. c Punch with tendon fragment. d wound with tendon defect
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Medium, Leica, Germany). Hematoxylin and eosin
staining was performed. On the basis of a semi-
quantitative four-point-scoring system (from 0 = normal
to 3 =markedly abnormal appearance) in six categories:
(1) fibre arrangement, (2) tendon fibre structure, (3)
regional variations in cellularity, (4) increased vascularity
and (5) scarring (decreased collagen staining) and (6)
hyalinisation were assessed as established by Longo et al
[17]. The final score results from the sum of the individual
scores given in each category.
Immunohistological analysis
Sliced tendon sections were stained using primary
monoclonal antibodies for collagen-type-I and collagen-
type-III (Sigma, Germany) in dilutions of 1:2000 (colla-
gen-type-I) and 1:4000 (collagen-type-III). Evaluation of
tendon staining was performed by dividing the tendons
into three parts (proximal, middle and distal third).
Staining grades were assessed as 0 (no staining), 1 (par-
tial staining) and 2 (strong staining). Immunohistological
analyses were performed by two blinded investigators.
Results
Macroscopic assessment
After 12 weeks all operated Achilles tendons were
completely recovered. No infections or other compli-
cations occurred. Macroscopic assessment showed
sporadic indurations in all groups within the former
defect zone.
Biomechanical testing
Ultimate load to failure
The mean ultimate load to failure ratio (treated side to
contralateral side) reached 97 % in the bFGF-group, 103 %
in the eGFP-group and 112 % in the PBS-group after the
12 weeks healing period (Fig. 3). However, the differences
between all groups were not significant (p = 0.310 for PBS
versus eGFP; p = 0.184 for PBS versus bFGF; and p = 0.567
for eGFP versus bFGF).
Stiffness
Stiffness of the operated tendons in comparison to the
contralateral untreated tendons (stiffness ratio) was
significantly lower across all groups (p = 0.000), in the
MSC-LV-eGFP-group (p = 0.001) and the MSC-LV-
bFGF-group (p = 0.014). A trend was observed in the
PBS-group but the difference was not significant (Fig. 4;
p = 0.070). Statistical analysis after the 84 days healing
period did not show any significant differences between
all groups.
Histological analysis
Assessment of hematoxylin and eosin staining showed
no significant differences between groups (Fig. 5 and
Table 1). Almost all tendons showed chondral ossifica-
tion. Dispositions of ossifications varied between separ-
ate, clustered and bar-shaped foci in the whole tendon
structure. Consistent distribution patterns could not be
identified. Tendon fibre structures were altered substan-
tially by ossifications. The semi-quantitative scoring does
not show relevant differences in the groups, also not in
the specific sub-categories.
In the immunohistological analysis collagen-type-I and
collagen-type-III staining showed no significant differ-
ences between groups (Fig. 6). Foci of ossification mostly
appeared positive for collagen-type-I but negative for
collagen-type-III. Remaining parts of tendons stained
strongly for collagen-type-I and collagen-type-III.
Discussion
The most important finding of this study was that in all
study groups biomechanical testing showed very good
Fig. 2 a specimen in testing machine. b macroscopic view of hind limb after testing. c detailed view of hind limb after testing
Fig. 3 Ultimate load [%] to contralateral side
(mean + standard deviation)
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healing potential achieving normal tendon strength
regarding load to failure values compared to the con-
tralateral tendon. However, all treated tendons gained
inferior results in stiffness. Lentiviral bFGF expression in
mesenchymal stem cells (MSC-LV-bFGF) did not signifi-
cantly affect the biomechanical or histological and
immunohistological results in comparison to MSC-LV-
eGFP group or the control group in this long-term rat
Achilles tendon model.
The histological analysis presented no improvement of
fibre structure after a long-term remodelling period.
Interestingly clusters of ossification were discovered in
almost all specimens throughout the study groups.
In literature one of the most promising approaches to
accelerate healing is the application of mesenchymal
stem cells [4–6, 18]. Besides their proliferation and
differentiation capacity into osteoblasts, chondrocytes,
adipocytes and fibroblasts [8] the beneficial effect of
MSCs may not be the differentiation into the regenerat-
ing tissue type, but rather the secretion at sites of injury
of growth factors such as IGF-1, TGF-ß, VEGF, PDGF,
and bFGF [9, 19, 20]. Therefore, not only the differenti-
ation potential but also the release of growth factors
distinguishes MSCs from tenocytes or fibroblasts. In this
context positive effects in the early stage of tendon heal-
ing were found by Chan et al. [12]. Their study showed
a positive effect on histological and immunohistological
repair characteristics only after seven days, using bFGF
as a one- time administered protein for patellar tendon
healing in a rat model.
In another recently published study in a rat rotator
cuff model adipose derived stem cells did not improve
the healing potential neither in the histological assess-
ment nor in the biomechanical investigation [7].
In a previous study [13] partially positive effects were
detected when MSC and bFGF expressed significantly
high values of collagen-type-I after two or four weeks.
However, although there were high amounts of collagen-
type-I in the MSC groups in short term assessment
long-term remodelling did not show significant dif-
ferences in tendon healing in this rat model. However,
the ultimate load to failure ratio showed a significant
improvement in the PBS-group from day 14 to day 84
(p = 0.000) and in the eGFP-group a significant increase
from day 14 to 84 (p = 0.004) [13]. The ultimate load to
failure ratio showed also improved results in the bFGF-
group, however, these findings were not significant
(p = 0.051 from day 14 to 84).
Ossification occurs as a known process in tendon
remodelling [3, 11]. Zhang et al. [21] showed in a tenot-
omy rat achilles tendon model investigating the effect of
a selective cox2 inhibitor that heterotopic ossification
developed in 100 % of the non treated group after
10 weeks. Similar findings are described by Pietschmann
et al. [22] in a tendon defect model with the use of
polyglycol acid and collagen-type-I scaffolds, seeded with
mesenchymal stem cells or tenocytes. Central ossifica-
tion and tendon-like tissue were observed after 16 weeks
in the superficial tendon layers in all study groups.
Fig. 4 Stiffness [%] to contralateral side (mean + standard deviation)
Fig. 5 Hematoxylin and eosin staining of the tendons after healing period of twelve weeks. Fibre structure remodelling is shown with chondral
ossifications. The MSC pictures show large amounts of ossifications (white clusters). These white clusters do not show a specific variation or
spreading in a, b or c
Table 1 Haematoxilyn and eosin staining after 12 weeks.
(p-value n.s.)
Group Number of tendons Score
medianValid Missing
bFGF 10 0 10 (7–10)
eGFP 10 0 10 (8–11)
PBS 10 0 9.5 (5–10)
Semi-quantitative scoring in six categories (0–18 points overall;
0 = normal – 3 = abnormal per category)
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Chondral metaplasia and endochondral ossification also
occurred in the healed tissue of both groups at 60 and
90 days in an Achilles tendon rat model with tenotomy,
suture and application of a gel with elastin-derived
peptide in the treated group [23]. Already in 1969, Salah
et al. [24] described heterotopic ossification in the Achil-
les tendon of the rat following crushing and ligation. In
a recently published study by Lui et al. ectopic ossifica-
tions were not seen after transplantation of allogeneic
tendon-derived stem cells (TDSC) in rat patellar tendon
model. However, biomechanical outcome is not reported
[25]. As a possible explanation for the suppression of os-
sifications weak immunoreactions and anti-inflammatory
effects of the TDSCs are reported [26]. As recently
reported the implantation of a surgical mesh loaded with
MSCs might be a promising approach. Schon et al.
found better histological results in a rat Achilles tendon
model in the mesh/MSC group than in the mesh group
or the control group alone. However, a biomechanical
investigation was not performed [27]. New research has
been performed with a tendon-derived, extracellular
matrix hydrogel in order to direct tendon regeneration
also in a rat Achilles tendon defect model [28]. In
biomechanical assessment in comparison to the contra-
lateral side, treated with saline, there were differences
between the groups observed after four weeks; however
no differences after two or eight weeks. In summary
application of stem cells and biologicals seems to have
positive effect in mid-term investigation at time points
between two to four weeks, but no longer lasting effects
in rat Achilles tendon models. A further promising
approach might be the application of calcium alginate
gels as stem cell matrix. Schmitt et al. have observed
paracrine stem cell activity and quantified concentra-
tions of bFGF and VEGF in cell culture supernatants.
The gels may function as immobilization matrices for
MSCs and therefore enhance healing after surgery [29].
In summary, no general conclusions about biologicals
in tendon healing can be drawn as tissue from individual
to individual differs and the healing potential of a young,
healthy rat might also be different than in a clinical
setting with degenerative tendons in humans [30].
However, this study is the first to report the outcome
after a long healing period of 12 weeks in a rat tendon
model. An investigation over such a long period has so far
not been performed, but still further investigation seems
necessary to finally develop promising approaches.
Conclusion
The biomechanical and (immuno)-histological results
did not show positive effects of the MSC groups on ten-
don remodelling in a long-term follow-up. Interestingly,
in later stages stem cells had potentially negative effects
on biomechanical results in comparison to two or four
week results. Chondral ossification occurred in all
groups after a twelve-week healing period.
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